SCHEMBL12366359

SCHEMBL12366359

[C-]#[N+]c1c(C(F)(F)F)cc(-c2ccccc2)n(Cc2ccncc2)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKN1 Q16512 1/20 0.43
PKN2 Q16513 1/20 0.43
CNR1 P21554 1/20 0.38
GRIN1 Q05586 3/20 0.38
GRIN2B Q13224 3/20 0.38
DCTPP1 Q9H773 1/20 0.38
CFTR P13569 1/20 0.36
RXRA P19793 1/20 0.36
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
HPGD P15428 2/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KDM4E B2RXH2 1/20 0.35
GSK3B P49841 1/20 0.34
CDC7 O00311 1/20 0.34
P2RX7 Q99572 1/20 0.34
CLPP Q16740 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366212 0.92 CNR1 (0.44) PKN1PKN2CNR1DCTPP1CFTR
SCHEMBL12366275 0.90 CFTR (0.42) CNR1DCTPP1CFTRRXRANR1H2
SCHEMBL12366238 0.90 DCTPP1 (0.42) CNR1DCTPP1CFTRRXRANR1H2
SCHEMBL12366364 0.89 GRIN1 (0.39) PKN1PKN2GRIN1GRIN2BHPGD
SCHEMBL12366351 0.88 AR (0.43) GRIN1GRIN2B
SCHEMBL12366320 0.88 KDM4E (0.47) CNR1DCTPP1RXRANR1H2NR1H3
SCHEMBL12366308 0.88 RXRA (0.43) CNR1DCTPP1RXRANR1H2NR1H3
SCHEMBL12366313 0.87 CNR1 (0.38) CNR1DCTPP1CFTRRXRANR1H2
SCHEMBL12366245 0.87 CNR1 (0.43) CNR1DCTPP1RXRANR1H2NR1H3
SCHEMBL12366395 0.85 CCR2 (0.44) CNR1DCTPP1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed